Along these lines, our previous study demonstrated a significant association between serum AGR2 concentration in CMT-afflicted dogs and distant tumor metastasis, as well as worse overall survival [14], suggesting the potential utility of serum AGR2 as a prognostic indicator for CMT. The gene discussed is AGR2; the disease is neoplasm.